Dublin, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other)" report to their offering. Genome editing is the process of modifying the DNA of a particular organism, by introducing breaks at specific, targeted locations in the genome. At the present time, ZFNs, TALENs and CRISPR-Cas9 are the most used and commercially developed technologies.
The report provides revenues and forecasts by technology, including: global revenues and forecast for the CRISPR-based market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); global revenues and forecast for the ZFN market by type of product, 2014-2020 (reagents & tools, Research services, Edited cell lines, Edited animal models, Total Market); global revenues and forecast for the TALEN market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); and global revenues and forecast for other gene editing technologies market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market). The competition has increased in recent years among the companies active in this market, particularly in the CRISPR/Cas9 segment, as new products have been developed and introduced to market. In 2016, multiple players participate in this market, from large multinational corporations to small, niche life sciences companies. These companies develop and commercialize various products and services for each of the major gene editing technologies.
Companies profiled in the report include include MilliporeSigma, Horizon Discovery Group, OriGene, ThermoFisher Scientific, and ToolGen. Gene editing technologies have a multitude of commercial applications in numerous fields, such as the development of human therapeutics, new varieties of plants, new breeds of animals, improved animal models for research, and novel sources of chemicals and energy. Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) provides detailed descriptions of these applications. Key Topics Covered: 1: Executive Summary
- Overview of Gene Editing
- Commercial Applications of Gene Editing Technologies
- Selected Commercial Gene Editing Products
- Industry Structure
- Market Trends
- Total Market Revenues and Forecast
2: Introduction and Applications of Gene Editing Technologies
- Overview of Gene Editing
- Current Major Genome Editing Technologies
- Commercial Applications of Gene Editing Technologies
- Human Therapeutics
- Plant Engineering
- Animal Breeding/Research Models
3: Gene Editing Technologies
- Zinc Finger Nucleases (ZFNs)
- Transcription Activator-Like Effector Nucleases (TALENs)
- Selected TALEN Gene Editing Products and Technologies
- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9
- Advantages and Limitations of CRISPR-Cas9 Technology
- Selected CRISPR-Cas9 Gene Editing Products
- Other Gene Editing Technologies
- Meganucleases
- The rAAV Technology
4: Industry Structure
- Tiers of Competition
- Barriers to Entry
- Competitive Factors
- Notable Mergers and Acquisitions
- Regulatory Aspects of Genetic Editing
- Market Trends
- Increasing Development of Therapeutics Using Gene Editing Technologies to
- Augment Market Revenues
- Intensified R&D Activity in Non-medical Fields to Accelerate Market Growth
- Increasing Investments and Funding in Gene Editing Area to Augment Market
- Revenues
- Growing Awareness about Gene Editing Technologies among Researchers to Spur
- Utilization of Gene Editing Technologies
- Limitations of Available Technologies to Constrain Market Growth
- Ethical Considerations to Restrain Utilization and Market Growth
- Regulatory Constraints to Impede Market Expansion
- Patent Disputes to Slow Market Growth
5: Total Market Revenues and Forecast
- Market Snapshot
- Total Market Forecast
- Market Revenues and Forecast by Technology
- Zinc Finger Nuclease (ZFN) Technologies
- TALEN Technologies
- CRISPR-based Technologies
- Other Gene Editing Technologies
6: Company Profiles
- Agilent Technologies, Inc.
- Allele Biotechnology
- Applied Biological Materials, Inc.
- Applied StemCell Inc.
- Caribou Biosciences, Inc.
- Cellectis, Inc.
- CRISPR Therapeutics AG
- Dharmacon
- DNA2.0, Inc.
- Editas Medicine
- GeneCopoeia
- GenScript
- Horizon Discovery Group, Plc
- Integrated DNA Technologies
- Intellia Therapeutics
- MilliporeSigma
- ZFN Products
- CRISPR/Cas9 Genome Editing Tools
- OriGene Technologies, Inc.
- PNA Bio, Inc.
- Precision BioSciences
- Sangamo Biosciences, Inc.
- Santa Cruz Biotechnology, Inc.
- System BioSciences
- Takara Bio USA (Clontech Laboratories)
- ThermoFisher Scientific
- TALEN Products
- CRISPR Products
- GeneArt Engineered Cell Models
- ToolGen, Inc.
- Transposagen, Inc.
- CRISPR-Cas9 Products
- XTN TALEN Products
- TriLink Biotechnology
For more information about this report visit http://www.researchandmarkets.com/research/6t...ne_editing
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Non Ferrous Metals, Enzymes
